Anesthesia – Sudair Pharma

Our Portfolio

Products in this therapeutic area

1 product manufactured or supplied by Sudair Pharma. Product information is intended for healthcare professionals; please refer to the approved prescribing information.

Surlex

Surlex® Indication: Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults, and by rocuronium in children and adolescents (2–17 years). Strength: 100 mg/ml Dosage Form: Solution for Injection Active Ingredient: Sugammadex

Manufactured to international standards

Every product in this portfolio is made under cGMP, in facilities aligned to SFDA, PIC/S, ISO and WHO expectations.

Enquiries

Looking for product information?

Our medical and regulatory teams can support healthcare professionals with product enquiries and prescribing information.